Standout Papers

Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcin... 2000 2026 2008 2017 2.8k
  1. Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma (2007)
    Gary R. Hudes, Michael A. Carducci et al. New England Journal of Medicine
  2. Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial (2010)
    Johann S. de Bono, Stéphane Oudard et al. The Lancet
  3. Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial (2007)
    Bernard Escudier, A Płużańska et al. The Lancet
  4. Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III Study (2000)
    Hans von der Maase, Steen Werner Hansen et al. Journal of Clinical Oncology

Immediate Impact

9 by Nobel laureates 3 from Science/Nature 85 standout
Sub-graph 1 of 17

Citing Papers

Current best practice for bladder cancer: a narrative review of diagnostics and treatments
2022 Standout
Prostate cancer
2021 Standout
38 intermediate papers

Works of I. Bodrogi being referenced

Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial
2010 Standout
Multinational, Double-Blind, Phase III Study of Prednisone and Either Satraplatin or Placebo in Patients With Castrate-Refractory Prostate Cancer Progressing After Prior Chemotherapy: The SPARC Trial
2009
and 4 more

Author Peers

Author Last Decade Papers Cites
I. Bodrogi 2374 6343 3498 4241 77 10.2k
Frédéric Rolland 2647 6597 4228 4685 141 11.3k
Christine Théodore 3797 5866 3394 2032 162 10.3k
Charles M. Baum 1404 8095 4641 5831 70 12.6k
Robert W. Ross 1536 3472 6050 3883 61 10.9k
Gary R. Hudes 1218 6724 3485 6084 101 10.5k
Tim Eisen 861 6902 4331 7341 145 12.6k
Wanling Xie 1011 5348 2769 3100 178 7.6k
A Płużańska 584 8129 6183 3165 65 11.4k
Jorge A. García 1029 6002 2053 2510 211 7.9k
Isan Chen 595 6901 3565 4715 41 8.9k

All Works

Loading papers...

Rankless by CCL
2026